No abstract available
MeSH terms
-
Adenocarcinoma of Lung
-
Adenocarcinoma* / complications
-
Adenocarcinoma* / metabolism
-
Adenocarcinoma* / pathology
-
Angiogenesis Inhibitors / administration & dosage
-
Antineoplastic Combined Chemotherapy Protocols / administration & dosage
-
Bevacizumab / administration & dosage*
-
Bone and Bones / diagnostic imaging*
-
Cyclooxygenase 2 / metabolism
-
Humans
-
Lung Neoplasms* / complications
-
Lung Neoplasms* / metabolism
-
Lung Neoplasms* / pathology
-
Male
-
Middle Aged
-
Neoplasm Staging
-
Osteoarthropathy, Secondary Hypertrophic* / diagnosis
-
Osteoarthropathy, Secondary Hypertrophic* / etiology
-
Radiography / methods*
-
Radionuclide Imaging / methods*
-
Radiotherapy, Intensity-Modulated / methods*
-
Superior Vena Cava Syndrome / diagnosis
-
Superior Vena Cava Syndrome / etiology
-
Treatment Outcome
-
Vascular Endothelial Growth Factor A / antagonists & inhibitors
-
Vascular Endothelial Growth Factor A / metabolism
Substances
-
Angiogenesis Inhibitors
-
Vascular Endothelial Growth Factor A
-
Bevacizumab
-
Cyclooxygenase 2
-
PTGS2 protein, human